Tara B. Gregory

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Colorado Blood Cancer Institute(Current)

Tennessee Oncology

Sarah Cannon

Tara B. Gregory is an author at Colorado Blood Cancer Institute specializing in immunotherapy, multiple myeloma therapy, and refractory multiple myeloma.

Publications per year

2022–2024

Publications

Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma

Binod Dhakal, Jesús G. Berdeja, Tara B. Gregory et al. · Blood · 2022 · 53 citations

Medicine, Pharmacology, Pharmacotherapy +13

Efficacy and Safety with Extended Follow-up in a Phase 1 Study of BMS-986393, a G Protein-Coupled Receptor Class C Group 5 Member D (GPRC5D)-Targeted CAR T Cell Therapy, in Patients (pts) with Heavily Pretreated Relapsed/Refractory (RR) Multiple Myeloma (MM)

Susan Bal, Larry D. Anderson, Omar Nadeem et al. · Blood · 2024 · 22 citations

Medicine, Immunology, Oncology +17

1–2 of 2